KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Receivables (2020 - 2025)

Oscar Health (OSCR) has disclosed Change in Receivables for 6 consecutive years, with -$2.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 117.67% year-over-year to -$2.9 million, compared with a TTM value of $101.9 million through Dec 2025, down 10.84%, and an annual FY2025 reading of $101.9 million, down 10.84% over the prior year.
  • Change in Receivables was -$2.9 million for Q4 2025 at Oscar Health, up from -$20.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $164.2 million in Q1 2025 and bottomed at -$98.0 million in Q3 2024.
  • Average Change in Receivables over 5 years is $18.9 million, with a median of $12.8 million recorded in 2021.
  • Peak annual rise in Change in Receivables hit 740.74% in 2024, while the deepest fall reached 703.68% in 2024.
  • Year by year, Change in Receivables stood at $14.7 million in 2021, then plummeted by 72.92% to $4.0 million in 2022, then surged by 170.12% to $10.8 million in 2023, then skyrocketed by 52.61% to $16.5 million in 2024, then tumbled by 117.67% to -$2.9 million in 2025.
  • Business Quant data shows Change in Receivables for OSCR at -$2.9 million in Q4 2025, -$20.0 million in Q3 2025, and -$39.4 million in Q2 2025.